GO
Loading...

Medtronic Inc

More

  • Final Glance: Medical Devices companies Tuesday, 23 Sep 2014 | 6:03 PM ET

    Allergan rose $3.06 or 1.8 percent, to $169.18. Baxter International Inc. fell$. 35 or. 5 percent, to $71.72. Boston Scientific Corp. fell$. 16 or 1.3 percent, to $12.17.

  • Carmax and Medtronic are big market movers Tuesday, 23 Sep 2014 | 4:22 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. Carmax Inc., down $5.01 to $47.80. Medtronic Inc., down $1.90 to $64.08.

  • *Action may deter Pfizer from returning to bid for AstraZeneca. WASHINGTON/ NEW YORK, Sept 23- Tough new U.S. rules on corporate "inversions" on Tuesday sent a chill through the market for the tax-avoidance deals, both pending and potential, with share prices falling sharply in nearly a dozen companies on both sides of the Atlantic.

  • Most active New York Stock Exchange-traded stocks Tuesday, 23 Sep 2014 | 1:20 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AbbVie fell 2.0 percent to $57.56 with 21,744,100 shares traded. Bank of America Corp. rose. 1 percent to $17.05 with 89,952,800 shares traded.

  • Midday Glance: Medical Devices companies Tuesday, 23 Sep 2014 | 1:20 PM ET

    Allergan rose $4.21 or 2.5 percent, to $170.33. Baxter International Inc. fell$. 39 or. 5 percent, to $71.68. Boston Scientific Corp. fell$. 16 or 1.3 percent, to $12.17.

  • The United States and Arab allies bombed Syria for the first time on Tuesday, killing scores of Islamic State fighters and members of a separate al Qaeda- linked group, opening a new front against militants by joining Syria's three-year-old civil war. AbbVie has agreed to a deal to acquire Shire, which fell 1.9 percent to $251.38 in New York.

  • *Action may deter Pfizer from returning to bid for AstraZeneca. Burger King, which is in the process of an inversion deal with Canada's Tim Horton's, said Tuesday it would proceed with its $11.5 billion deal despite the Treasury actions, saying the transaction was not about the tax benefits.

  • US clampdown on tax maneuver leaves its mark Tuesday, 23 Sep 2014 | 12:00 PM ET

    The pharmaceutical company AbbVie, based in Chicago, reached an agreement to buy Dublin- based Shire in July for $54 billion. AbbVie Inc. lost 2 percent in New York trading, while Shire sank 2 percent in London. said Jan Wald, an analyst at Benchmark Co., a financial advisory firm.

  • Early Glance: Medical Devices companies Tuesday, 23 Sep 2014 | 10:29 AM ET

    Allergan rose $4.31 or 2.6 percent, to $170.43. Baxter International Inc. fell$. 14 or. 2 percent, to $71.93. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.

  • Ahead of the Bell: Inversion rules sting stocks Tuesday, 23 Sep 2014 | 9:12 AM ET

    Shares of several companies stumbled Tuesday before markets opened and a day after the Treasury Department announced new regulations that aim to make it tougher to pull off overseas mergers and acquisitions that trim U.S. corporate tax bills. The new regulations are broader than Citi analysts Liav Abraham and Matthew J. Dodds expected.

  • *May deter Pfizer from returning to bid for AstraZeneca. LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. The move could jeopardize an agreed deal for AbbVie to buy Shire for $55 billion and deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • Europe, Syria drag on global stock markets Tuesday, 23 Sep 2014 | 4:09 AM ET

    NEW YORK— Grim economic news from Europe and airstrikes in Syria rattled global stocks Tuesday. Investors have been dealing with meager economic growth in Europe for months. "It has a very feeble recovery going on that is vulnerable to even the slightest external shock," said Jacob Kirkegaard, senior fellow at the Peterson Institute for International Economics.

  • WASHINGTON, Sept 22- Moving against tax-avoidance by corporations, the Obama administration is taking several actions to curb deals known as "inversions" that allow companies to escape U.S. taxes by reincorporating abroad.

  • Final Glance: Medical Devices companies Monday, 22 Sep 2014 | 6:03 PM ET

    Allergan fell $2.09 or 1.2 percent, to $166.12. Baxter International Inc. fell$. 47 or. 6 percent, to $72.07. Boston Scientific Corp. fell$. 08 or. 6 percent, to $12.33.

  • Midday Glance: Medical Devices companies Monday, 22 Sep 2014 | 2:12 PM ET

    Allergan fell $2.32 or 1.4 percent, to $165.89. Baxter International Inc. fell$. 63 or. 9 percent, to $71.91. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.30.

  • Final Glance: Medical Devices companies Friday, 19 Sep 2014 | 6:02 PM ET

    Allergan fell $1.76 or 1.0 percent, to $168.21. Baxter International Inc. fell$. 56 or. 8 percent, to $72.54. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.41.

  • Midday Glance: Medical Devices companies Friday, 19 Sep 2014 | 1:33 PM ET

    Allergan fell $2.45 or 1.4 percent, to $167.52. Baxter International Inc. fell$. 59 or. 8 percent, to $72.51. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.31.

  • Early Glance: Medical Devices companies Friday, 19 Sep 2014 | 10:16 AM ET

    Allergan fell $1.01 or. 6 percent, to $168.96. Baxter International Inc. fell$. 38 or. 5 percent, to $72.72. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.41.

  • Final Glance: Medical Devices companies Thursday, 18 Sep 2014 | 6:04 PM ET

    Allergan fell$. 07 or percent, to $169.97. Baxter International Inc. rose$. 45 or. 6 percent, to $73.10. Boston Scientific Corp. rose$. 20 or 1.6 percent, to $12.42.

  • Midday Glance: Medical Devices companies Thursday, 18 Sep 2014 | 1:18 PM ET

    Allergan fell$. 42 or. 2 percent, to $169.62. Baxter International Inc. rose$. 36 or. 5 percent, to $73.01. Boston Scientific Corp. rose$. 26 or 2.1 percent, to $12.48.